Morgan Stanley’s Cyclerion Therapeutics CYCN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.89K | Hold |
649
| – | – | ﹤0.01% | 7237 |
|
|
2025
Q1 | $1.62K | Hold |
649
| – | – | ﹤0.01% | 7214 |
|
|
2024
Q4 | $2.09K | Hold |
649
| – | – | ﹤0.01% | 7190 |
|
|
2024
Q3 | $1.68K | Hold |
649
| – | – | ﹤0.01% | 7163 |
|
|
2024
Q2 | $1.49K | Hold |
649
| – | – | ﹤0.01% | 7104 |
|
|
2024
Q1 | $2.08K | Sell |
649
-747
| -54% | -$2.39K | ﹤0.01% | 7060 |
|
|
2023
Q4 | $4.68K | Buy |
1,396
+573
| +70% | +$1.92K | ﹤0.01% | 7016 |
|
|
2023
Q3 | $2.82K | Hold |
823
| – | – | ﹤0.01% | 7051 |
|
|
2023
Q2 | $3.39K | Buy |
823
+221
| +37% | +$911 | ﹤0.01% | 7072 |
|
|
2023
Q1 | $5.23K | Buy |
602
+438
| +267% | +$3.8K | ﹤0.01% | 7038 |
|
|
2022
Q4 | $2.16K | Sell |
164
-6
| -4% | -$79 | ﹤0.01% | 7353 |
|
|
2022
Q3 | $3K | Sell |
170
-93
| -35% | -$1.64K | ﹤0.01% | 7374 |
|
|
2022
Q2 | $3K | Sell |
263
-1,696
| -87% | -$19.3K | ﹤0.01% | 7503 |
|
|
2022
Q1 | $43K | Sell |
1,959
-1,684
| -46% | -$37K | ﹤0.01% | 6779 |
|
|
2021
Q4 | $125K | Sell |
3,643
-82
| -2% | -$2.81K | ﹤0.01% | 6306 |
|
|
2021
Q3 | $229K | Buy |
3,725
+217
| +6% | +$13.3K | ﹤0.01% | 5926 |
|
|
2021
Q2 | $274K | Buy |
3,508
+1,619
| +86% | +$126K | ﹤0.01% | 5855 |
|
|
2021
Q1 | $105K | Sell |
1,889
-18,769
| -91% | -$1.04M | ﹤0.01% | 5977 |
|
|
2020
Q4 | $1.26M | Buy |
20,658
+17,540
| +563% | +$1.07M | ﹤0.01% | 4516 |
|
|
2020
Q3 | $379K | Buy |
3,118
+2,714
| +672% | +$330K | ﹤0.01% | 4777 |
|
|
2020
Q2 | $48K | Buy |
404
+265
| +191% | +$31.5K | ﹤0.01% | 5683 |
|
|
2020
Q1 | $7K | Sell |
139
-1,520
| -92% | -$76.5K | ﹤0.01% | 6102 |
|
|
2019
Q4 | $89K | Buy |
1,659
+1,160
| +232% | +$62.2K | ﹤0.01% | 5692 |
|
|
2019
Q3 | $121K | Buy |
499
+385
| +338% | +$93.4K | ﹤0.01% | 5368 |
|
|
2019
Q2 | $25K | Buy |
+114
| New | +$25K | ﹤0.01% | 5857 |
|